Ranjeet Kumar

Dr. Ranjeet Kumar

Pharmacology Physiology & Neuroscience, Rutgers, The State University of New Jersey, Newark, New Jersey, USA
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Environmental Research
Verified
Journal Article
Closed access
Ranjeet KumarRanjeet Kumar
Ranjeet Kumar
PDPravin S. Deshmukh
Pravin S. Deshmukh
SSsonal sharma
sonal sharma
BBBasu Dev Banerjee
Basu Dev Banerjee


14 January 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
Suman ChowdhurySuman Chowdhury
Suman Chowdhury
GWGusheng Wu
Gusheng Wu
ZLZi-Hua Lu
Zi-Hua Lu
Ranjeet KumarRanjeet Kumar
Ranjeet Kumar
RLRobert Ledeen
Robert Ledeen
The purpose of this study was to determine whether the age-related decline in a-series gangliosides (especially GM1), shown to be a factor in the brain-related etiology of Parkinson’s disease (PD), also pertains to the peripheral nervous system (PNS) and aspects of PD unrelated to the central nervous system (CNS). Following Svennerholm’s demonstration of the age-dependent decline in a-series gangliosides (both GM1 and GD1a) in the human brain, we previously demonstrated a similar decline in the normal mouse brain. The present study seeks to determine whether a similar a-series decline occurs in the periphery of normal mice as a possible prelude to the non-CNS symptoms of PD. We used mice of increasing age to measure a-series gangliosides in three peripheral tissues closely associated with PD pathology. Employing high-performance thin-layer chromatography (HPTLC), we found a substantial decrease in both GM1 and GD1a in all three tissues from 191 days of age. Motor and cognitive dysfunction were also shown to worsen, as expected, in synchrony with the decrease in GM1. Based on the previously demonstrated parallel between mice and humans concerning age-related a-series ganglioside decline in the brain, we propose the present findings to suggest a similar a-series decline in human peripheral tissues as the primary contributor to non-CNS pathologies of PD. An onset of sporadic PD would thus be seen as occurring simultaneously throughout the brain and body, albeit at varying rates, in association with the decline in a-series gangliosides. This would obviate the need to postulate the transfer of aggregated α-synuclein between brain and body or to debate brain vs. body as the origin of PD.

Verified
Journal Article
Open access
PDF file
Ranjeet KumarRanjeet Kumar
Ranjeet Kumar
Suman ChowdhurySuman Chowdhury
Suman Chowdhury
RLRobert Ledeen
Robert Ledeen
Research on GM1 ganglioside and its neuroprotective role in Parkinson’s disease (PD), particularly in mitigating the aggregation of α-Synuclein (aSyn), is well established across various model organisms. This essential molecule, GM1, is intimately linked to preventing aSyn aggregation, and its deficiency is believed to play a key role in the initiation of PD. In our current study, we attempted to shed light on the cytosolic interactions between GM1 and aSyn based on previous reports demonstrating gangliosides and monomeric aSyn to be present in neuronal cytosol. Native-PAGE and Western blot analysis of neuronal cytosol from mouse brains demonstrated the presence of both GM1 and monomeric aSyn in the neuronal cytosol of normal mouse brain. To demonstrate that an adequate level of GM1 prevents the aggregation of aSyn, we used NG108-15 and SH-SY5Y cells with and without treatment of 1-phenyl-2-palmitoyl-3-morpholino-1-propanol (PPMP), which inhibits the synthesis/expression of GM1. Cells treated with PPMP to reduce GM1 expression showed a significant increase in the formation of aggregated aSyn compared to untreated cells. We thus demonstrated that sufficient GM1 prevents the aggregation of aSyn. For this to occur, aSyn and GM1 must show proximity within the neuron. The present study provides evidence for such co-localization in neuronal cytosol, which also facilitates the inverse interaction revealed in studies with the two cell types above. This adds to the explanation of how GM1 prevents the aggregation of aSyn and onset of Parkinson’s disease.

5 February 2019 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
Ranjeet KumarRanjeet Kumar
Ranjeet Kumar
PDPravin S. Deshmukh
Pravin S. Deshmukh
SSSonal Sharma
Sonal Sharma
BBBasu Dev Banerjee
Basu Dev Banerjee

17 February 2012
Verified
Book Chapter
Open access
PDF file
Ranjeet KumarRanjeet Kumar
Ranjeet Kumar
SSSuparna Sanyal
Suparna Sanyal
Mycobacterium tuberculosis: Dormancy, Persistence and Survival in the Light of Protein Synthesis | InTechOpen, Published on: 2012-02-17. Authors: Ranjeet Kumar and Suparna Sanyal